Table 2 Outcomes
| Outcome | Baseline group | Academic detailing group | Computerised decision support group | P value# |
|---|---|---|---|---|
| N = 392 | N = 215 | N = 133 | ||
| Patients receiving recommended antibiotic cover for typical and atypical pathogens* |
211/341 61.9% |
143/208 68.7% |
113/126 89.7% | <0.01 |
| Patients requiring ICU who went direct from ED |
17/26 65.0% |
9/12 75.0% |
8/10 80% | 0.68 |
| Patients requiring ICU who received appropriate empiric broad spectrum antibiotics# |
12/25 48.0% |
5/11 45.0% |
9/10 90% | <0.01 |
| PSI class V patients who received appropriate empiric broad spectrum antibiotics# |
9/70 12.8% |
4/43 9.3% |
10/38 26.3% | <0.01 |
| PSI class IV&V patients who received appropriate empiric broad spectrum antibiotics # |
30/341 8.6% |
9/208 4.3% |
5/39 12.8% | <0.01 |
| CURB 'severe' patients who received appropriate empiric broad spectrum antibiotics# |
14/155 9.0% |
7/80 8.7% |
20/49 40.8% | <0.01 |
| Patients who received an antibiotic to which they had a known allergy |
11/42 26.2% |
6/23 26.1% |
3/21 14.3% | 0.50 |
| Time from ED presentation to administration of antibiotic: median (range) |
171 minutes (15–1969) |
158 minutes (15–1154) |
142 minutes (10–1190) | <0.01 |
| Average cost of antibiotics for pneumonia per patient | $72.07 | $94.47 | $84.04 | NA |